Skip to content
Research Today • Hope For Tomorrow

MK-0431-845

Merck 845

MK-0431-845, Merck 845, is a double blind, placebo controlled clinical trial investigating the efficacy and safety of continuing Sitagliptin vs withdrawl of Sitagliptin and introduction of Insulin Glargine.

Contact us to learn more
Scroll To Top